- 专利标题: Compositions and methods for treating CNS disorders
-
申请号: US15519480申请日: 2015-10-16
-
公开(公告)号: US10577390B2公开(公告)日: 2020-03-03
- 发明人: Gabriel Martinez Botella , Francesco G. Salituro , Albert J. Robichaud , Boyd L. Harrison
- 申请人: Sage Therapeutics, Inc.
- 申请人地址: US MA Cambridge
- 专利权人: Sage Therapeutics, Inc.
- 当前专利权人: Sage Therapeutics, Inc.
- 当前专利权人地址: US MA Cambridge
- 代理机构: Goodwin Procter LLP
- 代理商 Catherine M. McCarty; Christopher K. Haley
- 国际申请: PCT/US2015/056054 WO 20151016
- 国际公布: WO2016/061527 WO 20160421
- 主分类号: C07J43/00
- IPC分类号: C07J43/00 ; A61K45/06 ; C07J9/00 ; A61K31/575 ; A61K31/58 ; C07J1/00 ; C07J3/00 ; C07J5/00 ; C07J7/00 ; C07J11/00 ; C07J13/00 ; C07J21/00 ; C07J31/00 ; C07J41/00 ; C07J51/00 ; C07J71/00
摘要:
Described herein are neuroactive steroids of the Formula (I): or a pharmaceutically acceptable salt thereof; wherein (II), A, R1, R2, R3a, R4a, R4b, R5, R7a, and R7b are as defined herein. Such compounds are envisioned, in certain embodiments, to behave as GABA modulators. The present invention also provides pharmaceutical compositions comprising a compound of the present invention and methods of use and treatment, e.g., such for inducing sedation and/or anesthesia. (II)
公开/授权文献
- US20170240589A1 COMPOSITIONS AND METHODS FOR TREATING CNS DISORDERS 公开/授权日:2017-08-24
信息查询